2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
January 2nd 2015
With the FDA approval of several oral chemotherapy agents, the cost of medications to treat cancer is increasing rapidly. To control costs, legislators, patient advocates, and physicians have pushed for oral chemotherapy parity laws.
September 26th 2013
Afatinib (Gilotrif) tablets were approved by the FDA on July 15, 2013, as a first-line oral treatment for nonâ€“ small cell lung cancer with EGFR mutations. The oral tablets became commercially available in the United States September 2.